In the last 90 days, Medtronic plc insiders filed 0 open-market purchases and 3 sales; 2,151 institutions reported holding it in 13F filings for Q2 2026, worth $86.8B in total; no superinvestor holds it.
SEC filings
10-K, 10-Q, 8-K, 20-F and 40-F reports Medtronic plc filed with the SEC, newest first.
Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.
5.02Item 5.02: Departure or appointment of directors or officers; executive pay arrangements5.03Item 5.03: Amendment to the articles of incorporation or bylaws; change in fiscal year5.05Item 5.05: Amendment to or waiver of the code of ethics8.01Item 8.01: Other events9.01Item 9.01: Financial statements and exhibits
5.02Item 5.02: Departure or appointment of directors or officers; executive pay arrangements5.03Item 5.03: Amendment to the articles of incorporation or bylaws; change in fiscal year5.05Item 5.05: Amendment to or waiver of the code of ethics8.01Item 8.01: Other events9.01Item 9.01: Financial statements and exhibits
1.01Item 1.01: Entry into a material definitive agreement2.01Item 2.01: Completion of an acquisition or disposition of assets2.03Item 2.03: New direct financial obligation, such as new debt or an off-balance-sheet obligation3.01Item 3.01: Notice of delisting or failure to meet a listing rule; transfer of listing3.02Item 3.02: Unregistered sale of equity securities3.03Item 3.03: Material modification to the rights of security holders5.01Item 5.01: Change in control of the company7.01Item 7.01: Regulation FD disclosure9.01Item 9.01: Financial statements and exhibits
